Neutral
Envestnet Asset Management Inc. increases Pfizer stake by 1.8%, now holding 9.51M shares.
Envestnet Asset Management Inc. has raised its holdings in Pfizer Inc. by 1.8%, acquiring an additional 167,641 shares, bringing its total to 9.51 million shares valued at approximately $229.1 million. This move reflects continued institutional confidence in Pfizer's financial performance and strategic direction.
Key points
- Envestnet Asset Management Inc. increases Pfizer stake by 1.8%, now holding 9.51 million shares.
- Pfizer's Q2 2026 earnings beat expectations, reporting EPS of $0.77 and revenue of $15.03 billion.
- Analysts maintain a consensus "Hold" rating for Pfizer with an average price target of $28.28.
Sources
- Envestnet Asset Management Inc. Buys 167,641 Shares of Pfizer Inc. $PFEMarketBeat · September 25, 2026
- Pfizer Inc. $PFE Shares Bought by Waverly Advisors LLCMarketBeat · September 10, 2026
- Pfizer Inc. stock slips as BMO Capital keeps positive stance and options activity spikesAD HOC NEWS · September 9, 2026
AI-generated from public news sources. Not financial advice.
